Your browser doesn't support javascript.
loading
Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.
Menke, Joshua R; Aypar, Umut; Bangs, Charles D; Cook, Stephen L; Gupta, Srishti; Hasserjian, Robert P; Kong, Christina S; Lin, Oscar; Long, Steven R; Ly, Amy; Menke, Jacob A S; Natkunam, Yasodha; Ruiz-Cordero, Roberto; Spiteri, Elizabeth; Ye, Julia; Zadeh, Sara L; Gratzinger, Dita A.
Affiliation
  • Menke JR; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
  • Aypar U; Division of Cytogenetics, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Bangs CD; Division of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States.
  • Cook SL; Department of Laboratory Medicine, San Francisco Veterans Administration Health Care System, San Francisco, CA, United States.
  • Gupta S; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
  • Hasserjian RP; Division of Hematopathology, Department of Laboratory Medicine, San Francisco, CA, United States.
  • Kong CS; Division of Hematopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.
  • Lin O; Division of Cytopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
  • Long SR; Division of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Ly A; Division of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States.
  • Menke JAS; Division of Cytopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.
  • Natkunam Y; Senior Backend Engineer, Big Nerd Ranch, Atlanta, GA, United States.
  • Ruiz-Cordero R; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.
  • Spiteri E; Division of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Ye J; Divisons of Molecular Genetic Pathology, Cytopathology, and Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, United States.
  • Zadeh SL; Division of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States.
  • Gratzinger DA; Division of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States.
Front Oncol ; 14: 1408238, 2024.
Article in En | MEDLINE | ID: mdl-38903717
ABSTRACT

Introduction:

Fluorescence in situ hybridization (FISH) is an essential ancillary study used to identify clinically aggressive subsets of large B-cell lymphomas that have MYC, BCL2, or BCL6 rearrangements. Small-volume biopsies such as fine needle aspiration biopsy (FNAB) and core needle biopsy (CNB) are increasingly used to diagnose lymphoma and obtain material for ancillary studies such as FISH. However, the performance of FISH in small biopsies has not been thoroughly evaluated or compared to surgical biopsies.

Methods:

We describe the results of MYC, BCL2, and BCL6 FISH in a series of 222 biopsy specimens, including FNAB with cell blocks, CNBs, and surgical excisional or incisional biopsies from 208 unique patients aggregated from 6 academic medical centers. A subset of patients had FNAB followed by a surgical biopsy (either CNB or excisional biopsy) obtained from the same or contiguous anatomic site as part of the same clinical workup; FISH results were compared for these paired specimens.

Results:

FISH had a low hybridization failure rate of around 1% across all specimen types. FISH identified concurrent MYC and BCL2 rearrangements in 20 of 197 (10%) specimens and concurrent MYC and BCL6 rearrangements in 3 of 182 (1.6%) specimens. The paired FNAB and surgical biopsy specimens did not show any discrepancies for MYC or BCL2 FISH; of the 17 patients with 34 paired cytology and surgical specimens, only 2 of the 49 FISH probes compared (4% of all comparisons) showed any discrepancy and both were at the BCL6 locus. One discrepancy was due to necrosis of the CNB specimen causing a false negative BCL6 FISH result when compared to the FNAB cell block that demonstrated a BCL6 rearrangement.

Discussion:

FISH showed a similar hybridization failure rate in all biopsy types. Ultimately, MYC, BCL2, or BCL6 FISH showed 96% concordance when compared across paired cytology and surgical specimens, suggesting FNAB with cell block is equivalent to other biopsy alternatives for evaluation of DLBCL or HGBCL FISH testing.
Key words